Chelsea Therapeutics International Ltd. (CHTP) News

News for Chelsea Therapeutics International Ltd. (CHTP)

Sector News | Topic News

After Hours: $ 5.09

0.10 (+2.00%)

Volume: 200

5:45 PM EST Feb 10, 2012

Thu, Feb 09, 2012

8:30 AM

Patients With Neurological Diseases Like Parkinson's Disease May Also be Suffering From a Secondary Condition They Didn't Know Existed, New Survey Shows - Globe Newswire

Thu, Jan 26, 2012

8:45 AM

Chelsea Therapeutics Joins With Advocates, Patients and Experts to Raise Awareness of Neurogenic Orthostatic Hypotension (NOH) - Globe Newswire

Wed, Jan 11, 2012

9:25 AM

Chelsea Therapeutics Announces Exercise of Over-Allotment Option and Completion of the Public Offering of Common Stock - Globe Newswire

Fri, Jan 06, 2012

8:45 AM

Chelsea Therapeutics Prices Public Offering of Common Stock - Globe Newswire

Thu, Jan 05, 2012

4:03 PM

Chelsea Therapeutics Announces Proposed Public Offering of Common Stock - Globe Newswire

Tue, Jan 03, 2012

7:30 AM

Chelsea Therapeutics Announces FDA Advisory Committee Meeting Date for Review of NORTHERA(TM) NDA for the Treatment of Symptomatic NOH - Globe Newswire

Thu, Dec 22, 2011

7:30 AM

Chelsea Therapeutics Reports Topline Results From Phase II Trial of Droxidopa in Fibromyalgia - Globe Newswire

Thu, Dec 15, 2011

7:38 AM

Chelsea Therapeutics Receives Notice of Allowance of Key U.S. Patent for Novel, Controlled Release Formulation of Northera(TM) - Globe Newswire

Tue, Nov 29, 2011

7:30 AM

Chelsea Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference - Globe Newswire

Thu, Nov 17, 2011

7:30 AM

Chelsea Therapeutics Announces FDA Acceptance of NDA for Filing and Designation of Priority Review of NORTHERA(TM) for the Treatment of Symptomatic NOH - Globe Newswire

Wed, Nov 02, 2011

4:18 PM

Chelsea Therapeutics Reports Third Quarter 2011 Results - Globe Newswire

4:00 PM

Chelsea Therapeutics Announces Preliminary Results of Interim Analysis of CH-4051 Phase II Trial in Rheumatoid Arthritis - Globe Newswire

Thu, Oct 27, 2011

7:43 AM

Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2011 Results - Globe Newswire

Wed, Sep 28, 2011

7:30 AM

Chelsea Therapeutics Submits New Drug Application for NORTHERA(TM) (droxidopa) for the Treatment of Symptomatic NOH - Globe Newswire

Wed, Sep 07, 2011

8:01 AM

Chelsea Therapeutics to Present at the 13th Annual Rodman & Renshaw Global Healthcare Investment Conference - Globe Newswire

Tue, Sep 06, 2011

8:04 AM

Chelsea Therapeutics Receives New Patent for Use of Droxidopa in Fibromyalgia - Globe Newswire

Tue, Jul 26, 2011

8:00 AM

Preliminary Data From Exploratory Phase II Study Demonstrates Significant Activity of Droxidopa in Adult Attention Deficit Hyperactivity Disorder (ADHD) - Globe Newswire

Wed, Jul 20, 2011

7:30 AM

Chelsea Therapeutics to Host Conference Call to Discuss Second Quarter 2011 Results - Globe Newswire

Mon, Jun 20, 2011

7:30 AM

Chelsea Therapeutics Announces Successful Completion of Northera QTc Study - Globe Newswire

Wed, Jun 15, 2011

9:01 AM

Finding a Cure for Fragile Economy - Research Report on Chelsea Therapeutics International, Ltd. and Cyclacel Pharmaceuticals, Inc. - Marketwire

Thu, Jun 09, 2011

4:15 PM

Chelsea Therapeutics Announces New Data from Northera Phase III Program in Neurogenic Orthostatic Hypotension Presented at MDS 15th International Congress of Parkinson's Disease and Movement Disorders - Globe Newswire

Mon, May 09, 2011

4:06 PM

Chelsea Therapeutics Reports First Quarter 2011 Results - Globe Newswire

8:00 AM

Chelsea Therapeutics Announces Approval to Open Enrollment Into 3.0 mg Arms of CH-4051 Phase II Trial in Rheumatoid Arthritis - Globe Newswire

Mon, May 02, 2011

7:30 AM

Chelsea Therapeutics Announces Northera Poster Presentations and Symposium on Neurogenic Orthostatic Hypotension at MDS 15th International Congress of Parkinson's Disease and Movement Disorders - Globe Newswire

Thu, Apr 28, 2011

7:00 AM

Chelsea Therapeutics to Host Conference Call to Discuss First Quarter 2011 Results - Globe Newswire

First

1 2

Last